By Moneyvesta posted on November 18th, 2024

Dr. Reddy's Laboratories’arm recalling Morphine Sulfate extended release tablet, led to stock decline on the BSE

Dr. Reddy's Laboratories’ US-based subsidiary -- Dr Reddy's Laboratories Inc is recalling 2,040 bottles of 15 mg Morphine Sulfate extended-release tablets due to ‘Failed Impurities/Degradation Specification’. It is also recalling another 532 100-count bottles of the medication in 30 mg strength for the same reason.

Dr Reddy's initiated the Class II nationwide recall on October 22 this year.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Source: Ace Equity Nxt

Related Post

Play Store App Store Instagram Linkedin Whatsapp
Whatsapp Logo

Moneyvesta
Typically replies within an hour

Moneyvesta
×